Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together.
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning.
Read about our journey and get to know the leadership team at Vested
Emisphere Technologies, Inc. operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions. The company's preclinical programs focus on the development of oral formulations for the treatment of diabetes; and products in the areas of cardiovascular, appetite suppression, and pain, as well as in the development and expansion of nutritional supplement products. It has license agreements with Novo Nordisk A/S to develop and commercialize oral formulations of GLP-1 receptor agonists in combination with Emisphere carriers, as well as to develop and commercialize oral formulations of Novo Nordisk's insulin using the company's Eligen Technology. The company was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. Emisphere Technologies, Inc. was founded in 1986 and is based in Roseland, New Jersey. more
| Time Frame | EMIS | S&P500 |
|---|---|---|
| 1-Week Return | - | 2.35% |
| 1-Month Return | - | 3.2% |
| 3-Month Return | - | 8.36% |
| 6-Month Return | - | 23.97% |
| 1-Year Return | - | 18.53% |
| 3-Year Return | - | 78.04% |
| 5-Year Return | 41.71% | 110.78% |
| 10-Year Return | 1539.67% | 231.63% |
| Time Frame | EMIS | S&P500 |
|---|---|---|
| 1-Week Return | 0.00% | 235.74% |
| 1-Month Return | 0.00% | 46.70% |
| 3-Month Return | 0.00% | 38.49% |
| 6-Month Return | 0.00% | 54.61% |
| 1-Year Return | 0.00% | 18.53% |
| 3-Year Return | 0.00% | 21.20% |
| 5-Year Return | 7.22% | 16.08% |
| 10-Year Return | 32.27% | 12.74% |
| Sector | Weight |
|---|---|
|
Health Care | 100.00% |
Emisphere Technologies Inc (EMIS) share price today is $9.935.
Yes, Indians can buy shares of Emisphere Technologies Inc (EMIS) on Vested. To buy EMIS from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Emisphere Technologies Inc (EMIS) on Vested. You can start investing in Emisphere Technologies Inc (EMIS) with a minimum investment of $1.
The stock symbol (or ticker) of Emisphere Technologies Inc is EMIS.
Yes, you can setup SIP in Emisphere Technologies Inc shares. Follow the below steps to create the SIP:
Here is the historical performance of EMIS on the Vested app.
You can also access the top holdings, the expense ratio, and the sector breakdown for Emisphere Technologies Inc on Vested.
Link copied